vs

Side-by-side financial comparison of QUHUO Ltd (QH) and Zai Lab Ltd (ZLAB). Click either name above to swap in a different company.

QUHUO Ltd is the larger business by last-quarter revenue ($157.9M vs $127.1M, roughly 1.2× Zai Lab Ltd).

QUHUO Ltd. operates an on-demand lifestyle service platform focused on the Chinese mainland market. Its core offerings include gig workforce solutions, community group-buy services, and local life service matching for merchants and individual users, covering household services, catering operation support, and community retail segments to effectively connect service providers with end consumers.

Zai Lab Ltd is a global biopharmaceutical company focused on developing, manufacturing and commercializing innovative therapies for oncology, autoimmune disorders, infectious diseases and other unmet medical needs. It operates primarily in the Greater China region and partners with leading global biotech firms to expand access to life-saving treatments for underserved patient populations.

QH vs ZLAB — Head-to-Head

Bigger by revenue
QH
QH
1.2× larger
QH
$157.9M
$127.1M
ZLAB

Income Statement — Q2 FY2025 vs Q4 FY2025

Metric
QH
QH
ZLAB
ZLAB
Revenue
$157.9M
$127.1M
Net Profit
Gross Margin
51.0%
Operating Margin
-54.6%
Net Margin
Revenue YoY
17.1%
Net Profit YoY
EPS (diluted)
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
QH
QH
ZLAB
ZLAB
Q4 25
$127.1M
Q3 25
$115.4M
Q2 25
$157.9M
$109.1M
Q1 25
$105.7M
Q4 24
$108.5M
Q3 24
$101.8M
Q2 24
$222.9M
$100.1M
Q1 24
$87.1M
Net Profit
QH
QH
ZLAB
ZLAB
Q4 25
Q3 25
$-36.0M
Q2 25
$-40.7M
Q1 25
$-48.4M
Q4 24
Q3 24
$-41.7M
Q2 24
$-6.4M
$-80.3M
Q1 24
$-53.5M
Gross Margin
QH
QH
ZLAB
ZLAB
Q4 25
51.0%
Q3 25
59.5%
Q2 25
60.6%
Q1 25
63.6%
Q4 24
61.5%
Q3 24
64.1%
Q2 24
1.5%
64.9%
Q1 24
61.4%
Operating Margin
QH
QH
ZLAB
ZLAB
Q4 25
-54.6%
Q3 25
-42.3%
Q2 25
-50.3%
Q1 25
-53.3%
Q4 24
-62.6%
Q3 24
-66.6%
Q2 24
-2.7%
-76.0%
Q1 24
-80.7%
Net Margin
QH
QH
ZLAB
ZLAB
Q4 25
Q3 25
-31.2%
Q2 25
-37.3%
Q1 25
-45.8%
Q4 24
Q3 24
-40.9%
Q2 24
-2.9%
-80.2%
Q1 24
-61.4%
EPS (diluted)
QH
QH
ZLAB
ZLAB
Q4 25
$-0.05
Q3 25
$-0.03
Q2 25
$-0.04
Q1 25
$-0.04
Q4 24
$-0.09
Q3 24
$-0.04
Q2 24
$-0.08
Q1 24
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
QH
QH
ZLAB
ZLAB
Cash + ST InvestmentsLiquidity on hand
$4.3M
$689.6M
Total DebtLower is stronger
$858.0K
Stockholders' EquityBook value
$57.4M
$715.5M
Total Assets
$118.4M
$1.2B
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
QH
QH
ZLAB
ZLAB
Q4 25
$689.6M
Q3 25
$717.2M
Q2 25
$4.3M
$732.2M
Q1 25
$757.3M
Q4 24
$779.7M
Q3 24
$616.1M
Q2 24
$14.3M
$630.0M
Q1 24
$650.8M
Total Debt
QH
QH
ZLAB
ZLAB
Q4 25
Q3 25
Q2 25
$858.0K
Q1 25
Q4 24
Q3 24
Q2 24
$1.2M
Q1 24
Stockholders' Equity
QH
QH
ZLAB
ZLAB
Q4 25
$715.5M
Q3 25
$759.9M
Q2 25
$57.4M
$791.7M
Q1 25
$810.8M
Q4 24
$840.9M
Q3 24
$667.7M
Q2 24
$64.6M
$704.2M
Q1 24
$762.2M
Total Assets
QH
QH
ZLAB
ZLAB
Q4 25
$1.2B
Q3 25
$1.2B
Q2 25
$118.4M
$1.2B
Q1 25
$1.2B
Q4 24
$1.2B
Q3 24
$985.3M
Q2 24
$135.0M
$987.4M
Q1 24
$988.4M
Debt / Equity
QH
QH
ZLAB
ZLAB
Q4 25
Q3 25
Q2 25
0.01×
Q1 25
Q4 24
Q3 24
Q2 24
0.02×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
QH
QH
ZLAB
ZLAB
Operating Cash FlowLast quarter
$-5.8M
$-26.0M
Free Cash FlowOCF − Capex
$-26.7M
FCF MarginFCF / Revenue
-21.0%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-158.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
QH
QH
ZLAB
ZLAB
Q4 25
$-26.0M
Q3 25
$-32.0M
Q2 25
$-5.8M
$-31.0M
Q1 25
$-61.7M
Q4 24
$-55.8M
Q3 24
$-26.8M
Q2 24
$-42.2M
Q1 24
$-90.1M
Free Cash Flow
QH
QH
ZLAB
ZLAB
Q4 25
$-26.7M
Q3 25
$-35.0M
Q2 25
$-33.9M
Q1 25
$-63.2M
Q4 24
$-58.4M
Q3 24
$-28.2M
Q2 24
$-42.9M
Q1 24
$-91.1M
FCF Margin
QH
QH
ZLAB
ZLAB
Q4 25
-21.0%
Q3 25
-30.4%
Q2 25
-31.1%
Q1 25
-59.9%
Q4 24
-53.8%
Q3 24
-27.7%
Q2 24
-42.9%
Q1 24
-104.5%
Capex Intensity
QH
QH
ZLAB
ZLAB
Q4 25
0.5%
Q3 25
2.6%
Q2 25
2.6%
Q1 25
1.5%
Q4 24
2.4%
Q3 24
1.3%
Q2 24
0.7%
Q1 24
1.1%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

QH
QH

Segment breakdown not available.

ZLAB
ZLAB

Zejula$56.0M44%
Other$21.9M17%
Nuzyra$16.0M13%
Optune$11.9M9%
XACDURO$10.7M8%
Qinlock$9.7M8%
AUGTYRO$836.0K1%

Related Comparisons